Gene · 23327
Papers2,568
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,568
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Unanchored K63-linked polyubiquitin chains: a novel second messenger involved in G protein-coupled receptors early signaling events. | Cell Commun Signal | 2026 | 41507896 | PubTator, text mining | PubMed |
| Current understanding of ENaC regulation by P2Y2/PLC/PI(4,5)P2 pathway. | Purinergic Signal | 2026 | 41498836 | PubTator, text mining | PubMed |
| Rsp5/NEDD4 and ESCRT regulate TDP-43 toxicity and turnover via an endolysosomal clearance mechanism. | J Cell Biol | 2026 | 41498748 | PubTator, text mining | PubMed |
| PDIA3 Inhibition Facilitates Sensitivity of IKE-Induced Ferroptosis via STAT3/LCN2 Axis to Improve Glioblastoma Therapy. | Adv Sci (Weinh) | 2026 | 41391030 | PubTator, text mining | PubMed |
| NRF2 activation resolves neuropathic pain via dual antioxidant and NaV1.7-Suppressive mechanisms. | Mol Ther | 2026 | 41376164 | PubTator, text mining | PubMed |
| NEDD 4 Pyre-fighters to extinguish inflammation: NEDD4L ubiquitinates Gasdermin D and Gasdermin E to dampen pyroptosis. | Cell Death Differ | 2026 | 41366095 | PubTator, text mining | PubMed |
| Profiling the TRPV4 ankyrin repeat domain interactome and its disruption by neuromuscular disease-causing mutations. | J Biol Chem | 2026 | 41338459 | PubTator, text mining | PubMed |
| The SP1/NEDD4L Axis Suppresses the Breast Cancer Progression by Downregulating SNAI2 Expression. | Biochem Genet | 2026 | 41307818 | PubTator, text mining | PubMed |
| E3 Ubiquitin Ligase NEDD4L Regulates the TGF-β1/Smad Signaling Pathway to Mediate High-Glucose and High-Fat-Induced Ferroptosis of Hepatocytes. | Digestion | 2026 | 40743910 | PubTator, text mining | PubMed |
| Integrated network toxicology, machine learning algorithms and TMT proteomics reveal the mechanism of 18β glycyrrhetinic acid against gastric cancer. | Front Genet | 2025 | 41561975 | PubTator, text mining | PubMed |
| [Mechanism of ginsenoside Rb_1 in ameliorating hypoxia/reoxygenation injury in H9c2 cardiomyocytes through CTR1 ubiquitination-mediated regulation of cuproptosis]. | Zhongguo Zhong Yao Za Zhi | 2025 | 41507748 | PubTator, text mining | PubMed |
| Neuroligin-2 is ubiquitinated by Nedd4l to control developmental astrocyte morphogenesis. | bioRxiv | 2025 | 41446259 | PubTator, text mining | PubMed |
| Ferritinophagy-related prognostic genes UBE2Q1, NEDD4L, and TCP11L2 for prognosis prediction in sepsis. | Sci Rep | 2025 | 41361350 | PubTator, text mining | PubMed |
| Ion channel inhibition by targeted recruitment of NEDD4-2 with divalent nanobodies. | Nat Commun | 2025 | 41353348 | PubTator, text mining | PubMed |
| MMRN1 as a Potential Oncogene in Gastric Cancer: Functional Evidence from In Vitro Studies and Computational Prediction of NEDD4L-Mediated Ubiquitination. | Curr Issues Mol Biol | 2025 | 41296429 | PubTator, text mining | PubMed |
| Loss of CFIm activates YAP/TAZ and connects mRNA cleavage and polyadenylation inhibition to BRCAness. | bioRxiv | 2025 | 41278918 | PubTator, text mining | PubMed |
| Machine learning-powered discovery of a novel berberine derivative inducing SCD-dependent ferroptosis in osteosarcoma. | J Transl Med | 2025 | 41267108 | PubTator, text mining | PubMed |
| Correction: SLC7A11 upregulation via AR and NEDD4L ubiquitination contributes to ferroptosis inhibition and enzalutamide resistance in castration-resistant prostate cancer. | Cell Death Dis | 2025 | 41253772 | PubTator, text mining | PubMed |
| Normalization of trophoblast mTOR signaling rescues impaired function in primary human trophoblast cells isolated from pregnancies complicated by fetal growth restriction. | Cell Death Discov | 2025 | 41203646 | PubTator, text mining | PubMed |
| The miRNA Expression of Urinary Extracellular Vesicles in Patients With Gitelman Syndrome: The Role of hsa-let-7d-3p. | FASEB J | 2025 | 41182646 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23327/papers?page=4